Vanguard GNMA Outlook 2016
With the Fed hiking short-term interest rates for the first time in almost a decade in December, and signaling to investors that additional interest...
Vanguard GNMA: Slow and Steady
Slow and steady wins the race.
Beware Bio-tech risk in ETFs
Barrons’s had a nice piece over the weekend on the hidden exposures that may be lurking in your small-cap fund. Bio-tech stocks have been...
Vanguard GNMA Outlook 2015 Part II
In Part I of this series I explained the risks that investors are compensated for when they invest in Ginnie Mae mortgage backed securities....
Vanguard GNMA Outlook 2015
What is the outlook for mortgage backed securities and in particular GNMA Mortgage Backed Securities?
When Fundamentals Don’t Matter
Barron’s ran an article this weekend on the distortions ETF flows may be creating in individual stocks. This is an issue we have written...
Fidelity’s Winning Edge
You can see Fidelity’s winning edge is alive and well through its CEO Abigail Johnson. She runs it like a family business—for the long-term....
Vanguard GNMA 2014/2015
Nice 52-week run by Vanguard GNMA. As of January 31, 2015 the fund had returned 5.29% over the trailing twelve months. Shares yield 2.24%...
A Rising Tide Lifts all….er… Index Boats
Before you give your investment manager an ear full for trailing the S&P 500 last year, check out this article from Barron’s. Lots of...
A Darn Good Track Record
I always have money in the stock market and I always will. I don’t get worked up about big swings in stocks because I...